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The administration of leptin1 to leptin-deficient humans, and the
analogous Lepob/Lepob mice, effectively reduces hyperphagia and
obesity2,3. But common obesity is associated with elevated leptin,
which suggests that obese humans are resistant to this adipocyte
hormone. In addition to regulating long-term energy balance,
leptin also rapidly affects neuronal activity4–6. Proopiomelano-
cortin (POMC) and neuropeptide-Y types of neurons in the
arcuate nucleus of the hypothalamus7 are both principal sites of
leptin receptor expression and the source of potent neuropeptide
modulators, melanocortins and neuropeptide Y, which exert
opposing effects on feeding and metabolism8,9. These neurons
are therefore ideal for characterizing leptin action and the
mechanism of leptin resistance; however, their diffuse distribu-
tion makes them difficult to study. Here we report electrophysio-
logical recordings on POMC neurons, which we identified by
targeted expression of green fluorescent protein in transgenic
mice. Leptin increases the frequency of action potentials in the
anorexigenic POMC neurons by two mechanisms: depolarization
through a nonspecific cation channel; and reduced inhibition by
local orexigenic neuropeptide-Y/GABA (g-aminobutyric acid)
neurons. Furthermore, we show that melanocortin peptides
have an autoinhibitory effect on this circuit. On the basis of our
results, we propose an integrated model of leptin action and
neuronal architecture in the arcuate nucleus of the hypothalamus.
Previous studies suggest that leptin does not have equal effects on
all neuronal subtypes. Acute leptin treatment presumably activates
POMC, but not neuropeptide Y (NPY) neurons in the arcuate
nucleus of the hypothalamus (ARC), because c-Fos protein is
increased only in the former population and Socs3 messenger
RNA is increased in both10. Furthermore, a population of ARC
neurons seems to be inhibited directly by leptin, but the peptide
phenotype of these neurons has not been directly established11–14. In
addition to leptin receptors, both POMC and NPY neurons express
a receptor, MC3-R, for POMC-derived melanocortin peptides15.
The physiological role of this receptor is not well understood,
although MC3-R null mice have increased adiposity compared
with wild-type mice16.
To test the hypothesis that leptin selectively activates POMC
neurons, we first generated a strain of transgenic mice expressing
green fluorescent protein (EGFP; Clontech) under the transcrip-
tional control of mouse Pomc genomic sequences, including a
region located between -13 kilobases (kb) and -2 kb that is required
for accurate neuronal expression17 (Fig. 1a). Bright green fluores-
cence (509 nm) was seen in the two central nervous system regions
where POMC is produced: the ARC and the nucleus of the solitary
tract (data not shown).
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Under ultraviolet (450–480 nm) excitation, POMC neurons were
clearly distinguished from adjacent, non-fluorescent neurons (Fig.
1b) visualized under infrared optics. Double immunofluorescence
showed that there was more than 99% cellular colocalization of
EGFP and POMC peptides in the ARC (Fig. 1c). There was close
apposition of both tyrosine-hydroxylase- and NPY-stained termi-
nals on EGFP-expressing POMC neurons, but no evidence of
colocalization of the tyrosine hydroxylase or NPY immunoreactiv-
ity with EGFP (data not shown). Total fluorescent cell counts
of coronal hypothalamic sections determined that there were
3,148 6 62 (mean 6 s.e.m.; n = 3) POMC-EGFP neurons distrib-
uted through the whole ARC18 (Fig. 1d). POMC neurons are located
both medially and ventrally in mouse ARC, in contrast to a
predominantly lateral position in rat ARC.
POMC-EGFP neurons in hypothalamic slices had a resting
membrane potential of -40 to -45 mV and exhibited frequent
spontaneous action potentials. The non-selective opioid agonist
met-enkephalin (Met-Enk, 30 mM; Sigma) caused a rapid (35–
40 s), reversible hyperpolarization (10–20 mV) of the membrane
potential of POMC cells (n = 10) and prevented spontaneous action
potential generation (Fig. 2a). In normal (2.5 mM K+) Krebs
solution, the reversal potential of the inwardly rectifying opioid
current was about -90 mV, whereas in 6.5 mM K+ Krebs solution the
reversal potential shifted to about -60 mV (n = 3; Fig. 2b). The m-
opioid receptor (MOP-R) antagonist CTAP (1 mM; Phoenix Phar-
maceuticals) completely prevented the current induced by Met-Enk
in POMC cells (n = 3; Fig. 2c). These characteristics indicate that the
opioid current was caused by both activation of MOP-R and
increased ion conductance through G-protein-coupled, inwardly
rectifying potassium channels19. The similarity of opioid responses
in EGFP-labelled POMC neurons to those of guinea-pig19 or
I
M
–13 –2 0 9
EcoRI EcoRINotl
Length (kb)
transcriptional start translational stop
EGFP
1 2 3
Bregma –1.06 mm –1.22 mm
–1.58 mm
–1.34 mm
–1.70 mm
–1.46 mm
–1.82 mm –1.94 mm
Bregma –2.06 mm –2.18 mm –2.46 mm
–2.54 mm –2.80 mm–2.70 mm –2.92 mm
IR-DIC
Ultraviolet
Colocalization
b -endorphinEGFP
d
b
a
c
2 4 6 8
f
SOX
PaPo PaPo
Pe Pe
Pe
Pe
Pe
PeP
PeP
PeP
Pe
Arc
Arc
Arc Arc
ArcArcArc
Arc
Arc
Arc
Arc
mtmt
mt
mt
Gen
Gen
A12
Arc
Arc Arc
VMH VMH
SubI
VMH
VMH
PMD
PMV
VMH
AHP AHP
AHP
ME ME ME ME
MEME
TC
TC
VMH
VMH VMH
VMH
DM
DM
DM
DM
PH PH
PMV
PH
PHPH
DM
DM
DM
DTMDTM
DTM
DTM
SMT
SMT
SMT
SuMM
PMD
PMDPMV
SuM
SuM
SuM
SuMM
sumx sumx
sumx
pm
pm
mp
pm
MM MM
MM
LH
LM
VTM VTMMRe
LH
L
SMT
DM
3V
3V
3V
3V 3V3V
3V
3V
3V3V
MRe
3V
3V
3V
f f f
r
ff
fff
f
f f f
f
ff
–2.30 mm
ME
Figure 1 Generation of transgenic mice expressing EGFP in ARC POMC neurons.
a, Structure of the POMC-EGFP transgene. b, Identification of a single POMC neuron (red
arrowhead on recording electrode tip) by infrared-differential interference contrast
(IR-DIC) microscopy (upper) and EGFP fluorescence (lower) in a living ARC slice before
electrophysiological recordings. c, Colocalization (yellow) of EGFP (green) and b-
endorphin immunoreactivity (red) in ARC POMC neurons. Scale bars, 50 mm (b, c).
d, Distribution of EGFP-positive neuronal soma throughout the ARC nucleus. Green open
circles = 5 cells, green filled circles = 10 cells.
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Figure 2 Activation of MOP-Rs hyperpolarizes the EGFP-labelled POMC neurons by
opening G-protein-coupled inwardly rectifying potassium channels. a, Met-enkephalin
(Met-Enk) hyperpolarizes POMC neurons and inhibits all action potentials. Horizontal bar
indicates the time when 30 mM Met-Enk was bath applied to the slice. b, Met-Enk current
and reversal potential is shifted by extracellular K+ concentration. c, Met-Enk activates
MOP-Rs on POMC neurons. A Met-Enk (30 mM) current was observed, and the MOP-R-
specific antagonist CTAP (1 mM) was applied for 1 min. After CTAP, Met-Enk elicited no
current. Figure is representative of three experiments.
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mouse20 POMC cells, identified by post-recording immunohisto-
chemistry, suggests that expression of the EGFP transgene does not
compromise expression of receptors nor their coupling to second
messenger systems in POMC neurons.
We next determined the direct effects of leptin on identified
POMC cells in slice preparations. Leptin (0.1–100 nM) depolarized
72 out of 77 POMC cells by 3–30 mV (Fig. 3a; depolarization at
100 nM leptin, 9.7 6 1.2 mV (mean 6 s.e.m.; n = 45)) in 2–10 min,
in a concentration-responsive manner (Fig. 3b). There were two
components to the depolarization and neither were fully reversible
within 40 min. First, the depolarization was due to a small inward
current that reversed at about -20 mV (Fig. 3c), suggesting the
involvement of a nonspecific cation channel21. Second, leptin
treatment decreased the GABA-mediated tone onto POMC cells.
GABA-mediated inhibitory postsynaptic currents (IPSCs) were
observed in POMC cells, and leptin (100 nM) decreased their
frequency by 25% (Fig. 3d) in 5 out of 15 cells, indicating that it
may act presynaptically to reduce GABA release (leptin had no effect
on IPSCs in 10 out of 15 POMC neurons).
The effect on IPSC frequency occurred with a similar lag to the
effect on membrane potential. Thus, leptin not only directly
depolarizes POMC neurons but also acts at GABA-secreting nerve
terminals to reduce the release of GABA onto POMC neurons,
allowing them to adopt a more depolarized resting potential. The
consistent depolarization of POMC cells by leptin was specific
because leptin had no effect on 5 out of 13 adjacent non-fluorescent
cells tested (Fig. 3e), whereas it hyperpolarized five (Fig. 3f) and
depolarized three other non-POMC neurons in the ARC (data
not shown). The electrophysiological effects of leptin reported
here are consistent with leptin’s biological actions—leptin rapidly
causes release of a-melanocyte-stimulating hormone (a-MSH)
from rat hypothalami4, presumably by activating POMC neurons.
Previous reports of neuronal hyperpolarization by leptin11,12 and
the colocalization of GABA and NPY22 in subpopulations of ARC
neurons led us to speculate that leptin hyperpolarizes NPY/GABA
cells that directly innervate POMC neurons, and thus reduces
GABA-mediated drive onto POMC cells. Both leptin and NPY Y2
receptors are expressed on NPY neurons in the ARC7,23. Further-
more, activation of Y2 receptors inhibits NPY release from NPY
neurons24, and presumably would also diminish GABA release from
NPY/GABA terminals. This provided us with an alternative phar-
macological approach, independent of leptin, to test the proposed
innervation of POMC neurons by GABA-secreting NPY neurons.
Indeed, NPY (100 nM; Bachem) decreased the frequency of
GABA-mediated IPSCs by 55% in 3 min in all 12 POMC cells
tested (Fig. 4a). Both NPY and leptin still inhibited IPSCs in the
presence of tetrodotoxin (TTX; 6/6 and 3/5 cells, respectively),
indicating that some of the inhibition of IPSCs was occurring
through direct effects at presynaptic nerve terminals. POMC neu-
rons express the NPY Y1 receptor23, and NPYalso hyperpolarized all
POMC neurons tested by an average of 9 6 6 mV (n = 3; data not
shown).
To confirm the origin of GABA-mediated innervation on POMC
neurons from NPY/GABA terminals, we also tested the effect of the
highly selective MC3-R agonist D-Trp8-gMSH (ref. 25) on local
GABA release. D-Trp8-gMSH (7 nM) increased the frequency of
GABA-mediated IPSCs (280 6 90%) recorded from three out of
four POMC neurons (Fig. 4b). It had no effect on one cell. The
positive effect of MC3-R activation, together with the negative
effects of NPY and leptin, shows the dynamic range of the NPY/
GABA synapse onto POMC neurons and points to the important
role of this synapse in modulating signal flow in the ARC. D-Trp8-
gMSH (7 nM) also hyperpolarized (-5.5 6 2.4 mV) 9 out of 15
POMC neurons tested, and decreased the frequency of action
potentials (Fig. 4c); the remaining cells showed no significant
response to D-Trp8-gMSH. We could not determine whether these
effects were entirely due to increased GABA release onto the POMC
cells, or whether there was an additional postsynaptic action of D-
Trp8-gMSH on POMC neurons, roughly half of which also express
the MC3-R15. Thus, MC3-R acts in a similar autoreceptor manner to
MOP-Rs on POMC neurons, diminishing POMC neuronal activity
in response to elevated POMC peptides.
To determine that the IPSCs in POMC neurons were due to local
innervation by NPY/GABA cells, we carried out multi-label immuno-
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Figure 3 Leptin depolarizes POMC neurons through a nonspecific cation channel, and
decreases the GABA-mediated tone onto POMC cells. a, Leptin depolarizes POMC
neurons and increases the frequency of action potentials within 1–10 min of addition.
Figure is representative of recordings made from 77 POMC neurons. b, Leptin causes a
concentration-dependent depolarization of POMC cells. Depolarization by leptin was
determined at 0.1, 1, 10, 50 and 100 nM (effector concentration at half-maximum
response, EC50 = 5.9 nM) in 8, 7, 9, 3 and 45 cells, respectively. c, Leptin depolarizes
POMC cells by activating a nonspecific cation current. Figure is representative of the
response in ten cells. d, Leptin decreases the frequency of IPSCs in POMC cells. Figure is
an example of five cells in which leptin (100 nM) decreased the frequency of IPSCs.
e, Leptin had no effect on five adjacent non-fluorescent ARC neurons. f, Leptin
hyperpolarized five non-fluorescent ARC neurons.
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histochemistry using light and electron microscopy. Although
independent NPY27 and GABA27 innervation of POMC cells has
been reported, colocalization of NPY and GABA in nerve terminals
forming synapses onto POMC cells has not been shown. Similar to
the rat26, a dense innervation of POMC cells by NPYaxon terminals
was detected in the mouse (Fig. 4d). Electron microscopy confirmed
the co-expression of NPYand GABA in axon terminals, and showed
that these boutons established synapses on the perikarya of all 15
ARC POMC neurons analysed (Fig. 4e).
These observations allow us to propose a detailed model of
regulation of this circuit including: dual mechanisms of leptin
action in the ARC, interactions between NPY/GABA and POMC
neurons, and autoregulatory feedback from opioid and melano-
cortin peptides as well as NPY (Fig. 4f). In this model, leptin directly
depolarizes the POMC neurons while simultaneously hyper-
polarizing the somata of NPY/GABA neurons, and diminishes
release from NPY/GABA terminals. This diminished GABA release
disinhibits the POMC neurons. Together, the direct and indirect
effects of leptin result in an activation of POMC neurons and an
increased frequency of action potentials. In addition, both POMC
and NPY neurons express autoreceptors for some of their respective
neuropeptide products (b-endorphin or a-MSH, and NPY, respec-
tively) and activation of these autoreceptors may provide ultrashort
feedback loops that further modulate the effects of leptin on POMC
neurons. The effects of NPY and melanocortin agonists on IPSC
frequency are similar to the effect of NPY on IPSCs in the
paraventricular nucleus of the hypothalamus28.
Thus, there seem to be two classes of neurons accounting for
leptin sensitivity in the brain: those activated (depolarized) to
release anorexigenic peptides; and those inhibited (hyperpolarized)
with a consequent reduction in release of orexigenic peptides.
Identifying viable POMC neurons with EGFP provides an invalu-
able tool for determining complex actions on these important
neurons. Furthermore, an understanding of the acute effects of
leptin provides a model system for studying the mechanisms
underlying the development of leptin resistance29. M
Methods
Generation of POMC-EGFP mice
The EGFP cassette contains its own Kozak consensus translation initiation site, along with
SV40 polyadenylation signals downstream of the EGFP coding sequences, which directs
proper processing of the 39 end of the EGFP mRNA. We introduced the EGFP cassette by
standard techniques into the 59 untranslated region of exon 2 of a mouse Pomc genomic
clone containing 13 kb of 59 and 2 kb of 39 flanking sequences17. The transgene was
microinjected into pronuclei of one-cell-stage embryos of C57BL/6J mice (Jackson
Laboratories) as described17. One founder was generated and bred to wild-type C57BL/6J
to produce N1 hemizygous mice. In addition, we also generated N2 and subsequent
generations of mice homozygous for the transgene. The mice are fertile and have normal
growth and development.
Immunofluorescence and GFP colocalization
Anaesthetized mice were perfused transcardially with 4% paraformaldehyde, and free-
floating brain sections were prepared with a vibratome. We processed sections for
immunofluoresence and colocalization of GFP fluoresence using standard techniques.
Primary antisera and their final dilutions were rabbit anti-b-endorphin, 1:2500 (v/v);
rabbit anti-NPY, 1:25,000 (v/v) (Alanex Corp.); rabbit anti-ACTH, 1:2000 (v/v); and
mouse anti-TH, 1:1000 (v/v) (Incstar). After rinsing, sections were incubated with
10 mg ml-1 biotinylated horse anti-mouse/rabbit immunoglobulin-g (IgG) (Vector
Laboratories) followed by Cy-3 conjugated streptavidin, 1:500 (v/v) (Jackson Immuno-
research Laboratories). Photomicrographs were taken on an Axioscop (Zeiss) using
fluoroscein isothiocyanate (FITC) and rhodamine isothiocyanate (RITC) filter sets
(Chroma Technology Corp.).
Electrophysiology
We cut 200-mm thick coronal slices from the ARC of 4-week-old male POMC-EGFP mice.
Slices were maintained at 35 8C in Krebs solution ((in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl2,
2.4 CaCl2.2H2O, 1.2 NaH2PO4.H2O, 21.4 NaHCO3, 11.1 glucose), and were saturated with
95% O2 5% CO2 for 1 h before recordings. Recordings were made in Krebs solution at
35 8C. Slices were visualized on an Axioskop FS2 (Zeiss) through standard infrared optics
and using epifluoresence through a FITC filter set (see Fig. 1c). Whole-cell recordings were
made from fluorescent neurons using an Axopatch 1D amplifier (Axon Instruments) and
Clampex 7 (Axon Instruments).
We determined resting membrane potentials using an event-detection protocol on a
PowerLab system (AD Instruments) to average expanded traces of the membrane
potential. Drugs were applied to the bath over the times indicated. The resting membrane
potential was stable for up to 1 h in cells treated with Krebs solution alone (data not
shown). I–V relationships for the Met-Enk currents were established using a step protocol
(-60 mV holding potential, sequentially pulsed (40 ms) from -120 to -50 mV; cells were
returned to -60 mV for 2 s between voltage steps). The protocol was repeated after
addition of Met-Enk. The net current was the difference between the two I–V relation-
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Figure 4 The GABA-mediated inputs to POMC cells are from NPY neurons that co-express
GABA. a, NPY decreases the frequency of mini-IPSCs in POMC neurons. b, D-Trp8gMSH
(7nM)—a dose that selectively activates MC3-R—increases the frequency of GABA-
mediated IPSCs in POMC neurons. c, D-Trp8-gMSH hyperpolarizes POMC neurons.
Panels a–c are representative results. d, Expression of NPY in nerve terminals adjacent to
POMC neurons in the ARC. NPY nerve terminals (black, green arrowheads); POMC
neuronal soma (brown). Scale bar, 10 mm. e, Expression of GABA and NPY in nerve
terminals synapsing onto POMC neurons in the ARC. GABA immunoreactivity (10-nm gold
particles, red arrowheads) and NPY immunoreactivity (25-nm gold particles, green
arrows) are in separate vesicle populations colocalized in synaptic boutons that make
direct contact with the soma of POMC neurons (DAB contrasted with uranyl acetate and
lead citrate, diffuse black in cytoplasm). Scale bar, 1 mm. f, Model of leptin regulation of
NPY/GABA and POMC neurons in the ARC (see text).
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ships. This protocol was repeated in Krebs solution with 6.5 mM K+. To identify the
postsynaptic leptin current, I–V relationships were performed similarly with slow voltage
ramps (5 mV s-1 from -100 to -20 mV) before and 10 min after adding leptin (100 nM).
GABA-mediated IPSCs were recorded using a CsCl internal electrode solution ((in
mM): 140 CsCl, 10 HEPES, 5 MgCl2, 1 BAPTA, 5 Mg-ATP, 0.3 Na-GTP). Both mini IPSCs
and large amplitude (presumably multisynaptic) IPSCs were observed in the untreated
slices. TTX (1 mM) abolished large IPSCs. We acquired data before and after drug addition
at a -50-mV holding potential in 2-s sweeps every 4 s for the times indicated in the figures.
Mini-postsynaptic currents were analysed using Axograph 4 (Axon Instruments). IPSCs
and excitatory postsynaptic currents (EPSCs) were distinguished on the basis of their
decay constants; in addition, picrotoxin (100 mM) blocked all IPSCs. POMC neurons
receive a low EPSC tone, and the frequency was not modulated by any of the treatments
described here.
Immunostaining for light and electron microscopy
We carried out double immunocytochemistry for NPY and POMC using different colour
diaminobenzidine (DAB) chromogens on fixed mouse hypothalami according to
published protocols27. For electron microscopy, pre-embedding immunostaining for b-
endorphin was done with an ABC Elite kit (Vector Laboratories) and a DAB reaction,
followed by post-embedding labelling of GABA and NPY using rabbit anti-GABA, 1:1000
(v/v), and gold-conjugated (10-nm) goat anti-rabbit IgG or sheep anti-NPY and gold-
conjugated (25-nm) goat anti-sheep IgG. Sections were contrasted with saturated uranyl
acetate (10 min) and lead citrate (20–30 s), and examined using a Philips CM-10 electron
microscope.
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